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Abstract
Hypothesis: T cells modulate the antiviral and inflammatory responses of airway epithelial cells to human rhinoviruses
(HRV).
Methods: Differentiated primary human nasal epithelial cells (HNEC) grown on collagen-coated filters were exposed apically
to HRV14 for 6 h, washed thoroughly and co-cultured with anti-CD3/CD28 activated T cells added in the basolateral
compartment for 40 h.
Results: HRV14 did not induce IFNc, NOS2, CXCL8 and IL-6 in HNEC, but enhanced expression of the T cell attractant
CXCL10. On the other hand, HNEC co-cultured with activated T cells produced CXCL10 at a level several orders of
magnitude higher than that induced by HRV14. Albeit to a much lower degree, activated T cells also induced CXCL8, IL-6
and NOS2. Anti-IFNc antibodies and TNF soluble receptor completely blocked CXCL10 upregulation. Furthermore, a
significant correlation was observed between epithelial CXCL10 mRNA expression and the amounts of IFNc and TNF
secreted by T cells. Likewise, increasing numbers of T cells to a constant number of HNEC in co-cultures resulted in
increasing epithelial CXCL10 production, attaining a plateau at high IFNc and TNF levels. Hence, HNEC activation by T cells is
induced mainly by IFNc and/or TNF. Activated T cells also markedly inhibited viral replication in HNEC, partially through
activation of the nitric oxide pathway.
Conclusion: Cross-talk between T cells and HNEC results in activation of the latter and increases their contribution to airway
inflammation and virus clearance.
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Introduction
Common colds caused by viral respiratory infections are the
most frequent acute respiratory illness in humans. They can be
caused by a variety of different viruses including coronaviruses,
parainfluenza virus and respiratory syncytial viruses but infection
with rhinoviruses (HRV) of the Picornaviridae family is predom-
inant [1]. The antiviral response depends on the rapid production
of interferons (IFNs), which are classified as type 1 IFNs (IFNa/b)
and type 2 IFN (IFNc) based on the receptor complex used for
signalling as well as on their sequence homology [2,3]. Almost
every nucleated cell produces IFNa/b when infected by a virus,
whereas IFNc is mainly produced by T cells and NK cells. IFNa/
b mount robust host responses against viruses by inducing a wide
variety of antiviral proteins including ribonucleases that digest
viral double stranded RNA, and the antiviral protein kinase PKR
which induces apoptosis. Inducible nitric oxide synthase 2 (NOS2)
is also an important component of the innate immune response
[4,5], as it exerts direct antiviral activity by nitrolysating key thiol
residues in viral proteases.
Because respiratory epithelial cells are the main target for HRV
infection, numerous studies examined the primary direct airway
epithelial response to HRV exposure. In vitro infection of airway
epithelial cells with rhinovirus induces the production of a wide range
of antiviral molecules including INFb [6,7], b-defensins [8,9] as well
as NOS2 [10], or proinflammatory chemokines and cytokines that
attract and activate cells of the immune system, including CXCL8,
CXCL5, CXCL10, CCL5 and IL-6 [11–13]. During HRV
infections in vivo, levels of epithelial NOS2 induction correlate with
levelsofexhalednitricoxide(NO),andsubjectswiththehighestlevels
ofexhaledNOclearthevirusmorerapidlyandhave fewersymptoms
[14]. CXCL8 and IL-6 are present in nasal secretions and sputum of
HRV-infected individuals [15–20].
In the present study, we assessed the hypothesis that the
antiviral and inflammatory responses of upper airway epithelial
cells to human rhinoviruses are modulated by activated T cells.
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26293We developed an in vitro model with primary fully differentiated
nasal epithelial cells cultured on semi-permeable membranes
which separated them from the co-cultured T cells. Our data
revealed active cross-talk between epithelial cells and T lympho-
cytes, which impacted inflammation and virus clearance.
Materials and Methods
Epithelial cells culture
Human airway epithelial cells were obtained from patients after
partial middle turbinectomies. Patients gave informed verbal
Figure 1. Epithelial NOS2 mRNA expression and NO release are induced by T cells but not HRV14.HNEC were either not infected (C) or
exposed apically to HRV14 alone (HRV), or co-cultured with activated T cells alone (T cells), or exposed to HRV14 washed thoroughly then co-cultured
with activated T cells (HRV+T cells). (A) mRNA was determined by real-time PCR and data represented as fold increase relative to non-infected cells
cultured without T cells. (B) NO secretion is expressed as the amount of nitrite (the stable oxidation product of NO) released in the apical and
basolateral compartments (mM). Shown are the boxplots with the 25
th,5 0
th (median), 75
th percentiles, the mean (open square), the maximum and the
minimum values. *p,0.05. **p,0.05 compared with HRV-infected cells.
doi:10.1371/journal.pone.0026293.g001
Role of T Lymphocytes in Airway Inflammation
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26293Role of T Lymphocytes in Airway Inflammation
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26293consent which was documented in the patient’s chart. Both the
verbal consent procedure and the present protocol were
specifically approved by our institution’s ethical committee.
Because material provided by surgical samples was handed
anonymously to the research laboratory, the requirement for
written consent was waived by the ethical review board. The name
of the institutional ethical review board is: Commission Centrale
d’Ethique de la Recherche, Ho ˆpitaux Universitaires de Gene `ve.
Cells were isolated by pronase (Roche, Mannheim, Germany)
digestion, and seeded onto collagen-coated Millicell polycarbonate
filters (Millipore, MA, USA) as described [21]. Twenty four hours
after plating, the mucosal media is removed and the cells are
allowed to grow with an air-liquid interface which permits the cells
to develop a morphological and functional phenotype that closely
resembles in vivo airway epithelium. The culture media consisted
of a 1:1 mix of DMEM:F12 (Life Technologies, CA, USA),
100 U/ml penicillin, 100 mg/ml streptomycin and 50 mg/ml
fungizone (DMEM:F12/PSF), 2% Ultroser G (Pall-Biosepra,
Cergy-Saint-Christophe, France). Cells were used after 2–3 weeks
of culture.
T cell preparation and activation
Human peripheral blood mononuclear cells (PBMC) were
prepared from whole blood of normal individuals using Ficoll
Hypaque density centrifugation. T cells were isolated from PBMC
by negative immunomagnetic selection using the Dynal T cell
negative isolation kit (Life Technologies, CA, USA). T cells thus
isolated were activated with CD3/CD28 T Cell Expander
artificial antigen-presenting cell beads (Life Technologies, CA,
USA) at a ratio of 2:1.
T cell clones preparation
T cell clones were generated from PBMC of a normal individual
upon antigen activation and cloning by limiting dilution in RPMI
1640 medium supplemented with penicillin (50 U/ml), strepto-
mycin (50 mg/ml), 5% human serum, IL-2 (20 U/ml) and
irradiated (3500 rads) autologous PBMC with phytohaemaggluti-
nin (1 mg/ml). Growing cells were further expanded and activated
with CD3/CD28 T Cell Expander artificial antigen-presenting
cell beads (Life Technologies, CA, USA) at a ratio of 1:1.
Viruses
Human rhinovirus type 14 (HRV14) was obtained from the
American Type Culture Collection, and propagated by infection
of Hela-Ohio cells (kindly provided by Prof. FG Hayden,
University of Virginia, Charlottesville, VA, USA) in MEM
containing 10% FCS. Cells were infected for 18 h at 33uC,
washed and further cultured in McCoy’s 5A Medium (Invitrogen,
Life Technologies, CA, USA), 2% FCS for 2 days at 33uC. Virus
containing supernatants were then collected. The viral stocks were
partially purified and concentrated using the Amicon Ultra-4
centrifugal filter devices (Millipore, MA, USA) with a molecular
weight cut-off of 100 kDa, according to the manufacturer’s
instructions. Viruses were titrated on HeLa-Ohio cells to ascertain
tissue culture infective dose 50 (TCID50), which was calculated
using the formula of Reed and Muench [22].
Treatments of HNEC
All treatments were done in DMEM:F12/PSF without Ultroser
G.
HRV14 infection. HRV14 in a 100 ml volume was added
apically to HNEC at a concentration of 0.5610
5 TCID50/ml.
Cells were incubated with the viruses at 33uC for 6 h. To
determine the viral load of the cells, after infection HNEC were
washed extensively, and incubated at 33uC for 18 h, 40 h and
60 h in DMEM:F12/PSF with an air liquid interface. HNEC-T
cells co-culture experiments were performed at 33uC for 40 h in
the absence or presence of T cells.
HNEC-T cells co-cultures. For all experiments except the
dose-response experiment, 0.560
6 of purified non-activated and
CD3/CD28 activated T cells or T cell clones were added in the
basolateral compartment. For the dose-response experiment,
increasing amounts of non-activated and activated T cells (0.1,
0.5, 2.5 and 5610
6 T cells) were used per well. For each
experiment, HNEC obtained from biopsies of one anonymous
donor were co-cultured with T cells isolated from PBMC of one
anonymous healthy donor. Since HNEC were grown on Millicell
inserts and T cells were present only in the lower chamber, there
was no direct contact between cell populations. In parallel,
unstimulated and activated T cells were also cultured separately
without HNEC.
Incubation with IFNc neutralizing antibody. HNEC were
co-cultured with activated T cells in the absence or presence of
either isotype matched IgG or neutralizing anti-IFNc (1 mg/ml,
RD Systems, Abingdon, UK).
Incubation with TNF soluble receptor. HNEC were co-
cultured with activated T cells in the absence or presence of
10
27 M TNF soluble receptor p75 (a kind gift from Amgen, CA,
USA).
Fluticasone propionate (FP) treatment. Epithelial cells
were pretreated apically and basolaterally with 500 nM FP
(Sigma-Aldrich, Buchs, Switzerland) for 24 h prior to exposure
to HRV14. FP was maintained in the basolateral compartment
throughout the 40 h post-infection in the absence or presence of
activated T cells.
N6-(1-Iminoethyl)-L-lysine hydrochloride (L-NIL) treatment. L-
NIL (Calbiochem, Merck Chemicals, Nottingham, UK), a
selective inhibitor of inducible nitric oxide synthase, was
present (100 mM) during the 6 h HRV infection period, and
throughout the 40 h post-infection period in the absence and
presence of activated T cells.
Treatment with recombinant cytokines. HNEC were
exposed basolaterally to IFNc plus TNF (50 ng/ml each, Sigma-
Aldrich, Buchs, Switzerland) for 48 h.
After treatments, apical washings and basolateral media
were collected, centrifuged at 1000 rpm at 4uC to remove cell
debris and T cells (co-cultures experiments), stored at 220uC
for chemokines/cytokines measurement. Epithelial cells were
scrapped from the inserts in RNA lysis buffer and stored at
220uC for RNA extraction. For T cells cultures alone, the culture
media containing T cells were harvested and centrifuged at
1000 rpm. The supernatants were saved for chemokines/cytokines
measurement, and the T cells pellets were lysed in RNA lysis
buffer. The anti-CD3/CD28 coated beads were removed from the
Figure 2. Epithelial CXCL10 mRNA is induced by HRV14 and T cells, CXCL8 and IL-6 mRNA are induced only by T cells.HNEC were
exposed apically to HRV14 alone (HRV), or co-cultured with activated T cells alone (T cells), or exposed to HRV14 washed thoroughly then co-cultured
with activated T cells (HRV+T cells). The expression of CXCL10 mRNA (A), CXCL8 mRNA (B) and IL-6 mRNA (C) was determined by real-time PCR. Data




percentiles, the mean (open square), the maximum and the minimum values. *p,0.05 compared with control non-infected cells. **p,0.05 compared
with HRV-infected cells.
doi:10.1371/journal.pone.0026293.g002
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USA).
RNA extraction and quantitative real time PCR
Total RNA was extracted from epithelial cells and T
lymphocytes using the RNeasy Micro kit (Qiagen, CA, USA)
following the manufacturer’s instructions, and quantitated with
standard UV absorbance measurements. Complementary DNA
was synthesized with an oligo(dT) primer and Superscript II,
under standard conditions. mRNA levels for CXCL10, CXCL8,
IL-6, IFNb and IFNc were quantified relative to 18S RNA, using
SYBR Green-based quantitative real time PCR on a GeneAmp
5700 Sequence Detection System (Applied Biosystems, Life
Technologies, CA, USA). The primers and SYBR Green/Rox
PCR master mixes were from SABiosciences (Qiagen, CA, USA).
HRV14 RNA was quantified relative to 18S RNA by real-time
PCR using the Panenterhino/Ge/08 combination, as previously
described [23].
Cytokines and chemokines determination
Culture media were assayed for CXCL8, CXCL10, IL-6, and
IFNc proteins using the Ten-Plex Bead Immunoassay and
methods provided by the manufacturer (BioSource, Life
Technologies, CA, USA). TNF amounts released in the culture
m e d i ab ya c t i v a t e dTc e l l sa n dTc e l lc l o n e sw e r em e a s u r e db y
ELISA (eBioscience, Vienna, Austria). In HNEC/T cells co-
cultures experiments, the amounts of cytokines/chemokines
secreted by epithelial cells in the basolateral compartments were
determined by subtracting the amounts of cytokines/chemo-
kines measured in the culture media of activated T cells cultures
alone.
Nitrite determination
Levels of nitrite, the stable oxidation product of NO, in the
apical and basolateral compartments were measured using a
colorimetric assay based on the Griess reaction (Molecular Probes,
Life Technologies, CA, USA).
Statistical analysis
The significance of the difference between groups (p,0.05) was
determined with the nonparametric Kruskal-Wallis and Mann-
Whitney tests for unpaired samples using the Statview program for
Windows (Version 5.0.1, SAS Institute Inc.). Data are presented as




maximum and the minimum values.
Results
HRV14 replicate in differentiated HNEC
To ascertain that differentiated HNEC were infected after a 6 h
period incubation with 5000 TCID50 HRV14, viral RNA levels
were determined in cells by real-time RT-PCR at 18 h, 40 h and
60 h post-infection. There was a time-dependent increase in
intracellular viral RNA, by 7.5 fold (median) at 40 h (min 1.4, max
34, n=8), and 65 fold (median) at 60 h (min 1.5, max 209; n=8)
compared with that observed at 18 h post-infection.
Since several previous in vivo experimental HRV inoculation
studies reported that nasal viral titers peaked on day 2 post-
inoculation [20,24,25] and were correlated with peak symptom
scores [20,24], we chose the 40 h post-infection time point for
HNEC-T cells co-cultures experiments.
Figure 3. Both HRV14 and T cells enhance CXCL10, but only T cells enhance CXCL8 and IL-6 protein secretion by HNEC.HNEC were
either not infected (C) or exposed apically to HRV14 alone (HRV), and co-cultured or not with activated T cells (T cells). The production of CXCL10 (A),




percentiles, the mean (open square), the maximum and the minimum values. *p,0.05. In co-cultures experiments, the amounts of cytokines/
chemokines released by epithelial cells in the basolateral compartments were determined by subtracting the amounts of cytokines/chemokines
measured in the culture media of activated T cells cultures alone (undetectable for CXCL10, 0.034 ng/ml for CXCL8, 10.6 pg/ml for IL-6, median).
doi:10.1371/journal.pone.0026293.g003
Figure 4. Anti-IFNc and TNF soluble receptor p75 strongly
reduce epithelial CXCL10 mRNA expression but only partially
attenuate epithelial NOS2 expression induced by T cells.HNEC
were co-cultured with activated T cells in the absence or presence of
anti-IFNc, TNF soluble receptor (srTNF) or an isotype-matched antibody
(IgG). CXCL10 (A) and NOS2 (B) mRNA were measured by real-time PCR.
Data are presented as fold change relative to those obtained in the




th percentiles, the mean (open square), the maximum
and the minimum values. *p,0.05 compared with isotype matched IgG
treated cultures. #p,0.05 compared with anti-IFNc and srTNF treated
cultures.
doi:10.1371/journal.pone.0026293.g004
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mRNA expression and NO release
The antiviral factors IFNb and NOS2 are important in
immediate innate immune response. We assessed their production
in HNEC exposed to HRV14, activated T cells, or both. IFNb
mRNA expression was not affected by HRV14, activated T cells
or both stimuli (data not shown). A short term exposure to HRV14
did not affect epithelial NOS2 mRNA expression (Fig. 1A) and
NO release by HNEC (Fig. 1B). Activated T cells in co-culture
with HNEC significantly induced epithelial NOS2 mRNA level
(Fig. 1A), corroborated by an increase in the basolateral secretion
of nitrite (Fig. 1B). Unstimulated T cells showed no stimulatory
effects (data not shown).
Both HRV14 and activated T cells induce epithelial
CXCL10, but only activated T cells induce CXCL8 and IL-6
Chemokines and cytokines that permit recruitment and
activation of immune cells are essential to adaptive immune
responses to viral infections. CXCL10 and CXCL8 exert
chemotactic acitivity towards activated T lymphocytes and
neutrophils, respectively. We assessed their production, and that
of the pro-inflammatory cytokine IL-6 in HNEC exposed to
HRV14, activated T cells, or both.
HRV14 significantly increased mRNA expression of CXCL10,
but did not affect that of CXCL8 and IL-6 in epithelial cells
(Fig. 2A–B–C). Co-culture of activated T cells with HNEC
boosted chemokines and cytokine production. In particular,
epithelial CXCL10 mRNA expression increased considerably.
Unstimulated T cells had no effect (data not shown).
CXCL10, CXCL8 and IL-6 proteins were detected in both the
apical and basolateral compartments (Fig. 3A–B–C). HRV14
induced a significant increase in basolateral secretion of CXCL10
(p=0.03) without affecting that of CXCL8 and IL-6. Consistent
with mRNA data, activated T cells co-cultured with HNEC
greatly enhanced the apical and basolateral secretion of CXCL10,
CXCL8, and IL-6.
The stimulating effects of HRV14 and activated T cells were
neither additive nor synergistic.
Anti-IFNc and TNF soluble receptor p75 strongly inhibit
CXCL10 and partially attenuate NOS2 mRNA expression
induced in HNEC by activated T cells
Since CXCL10 gene promoter contains GAS (Gamma
Activating Sequence) and ISRE (Interferon Regulatory Factor
response Element) that are important for IFNc-mediated gene
expression, and NFkB (Nuclear Factor kappa B) that is
important for TNF-induced ge n ee x p r e s s i o n[ 2 6 ] ,w ea s k e d
whether the stimulating effects of activated T cells were
mediated by IFNc and/or TNF secreted by T cells in the
media. We thus examined the effects of activated T cells in co-
culture with HNEC in the presence of neutralizing anti-IFNc
and TNF soluble receptor p75. The T cells induced increase in
epithelial CXCL10 mRNA expression was significantly reduced
by 7062% by neutralizing IFNc with a specific antibody, and
by 8563% by neutralizing TNF with its soluble receptor p75.
Neutralizing both IFNc and TNF resulted in 9562% reduction
(Fig. 4A).
The T cells induced increase in epithelial NOS2 mRNA
expression was reduced by 4268% by anti-IFNc,a n db y
4763% by TNF soluble receptor p75 (Fig. 4B). The effects of
anti-IFNc and TNF soluble receptor were not additive or
synergistic.
Figure 5. Epithelial CXCL10 mRNA induction is proportional to the amounts of IFNc and TNF produced by T cell clones. HNEC were
co-cultured with T cell clones obtained from PBMC of a normal individual. CXCL10 mRNA induction is expressed as a function of IFNc (A) and TNF (B)
secreted by T cell clones in the culture medium. Epithelial CXCL10 mRNAs are measured by real-time PCR and expressed as fold increase relative to
those measured in epithelial cells cultured without T cells. IFNc and TNF were measured by TenPlex bead immunoassay and ELISA.
doi:10.1371/journal.pone.0026293.g005
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cell clones strongly correlate with the secreted amounts
of IFNc and TNF
We extended these findings by examining the effects of T
cell clones that secreted different amounts of IFNc and TNF,
in co-cultures with HNEC. In concordance with data from
neutralizing experiments, the degree by which T cells clones
stimulated CXCL10 expression was proportional to their
potency to produce IFNc or TNF (Fig. 5A,B). When
correlating epithelial CXCL10 mRNA levels with IFNc
protein secreted by T cell clones, a significant linear
relationship could be detected (r=0.97, p=0.0001). We also
observed a linear correlation between epithelial CXCL10 and
T cell derived TNF, but the correlation was statistically less
significant (r=0.62, p=0.034). Unstimulated T cell clones
were ineffective (data not shown).
Epithelial CXCL10 protein secreted into the basolateral
compartment increases with increasing numbers of T
cells and amounts of IFNc and TNF, attaining a plateau at
high concentrations
Increasing numbers of activated T cells (0.1, 0.5, 2.5 and 5610
6)
to a constant number of HNEC (0.5610
6) in co-cultures resulted
in increased basolateral secretion of epithelial CXCL10 with a
maximum at 2.5610
6 T cells (Fig. 6A). When correlating the
amount of CXCL10 secreted by HNEC with the amounts of IFNc
and TNF secreted by increasing numbers of T cells, a saturation
curve was obtained with a plateau at IFNc level.10 ng/ml
(Fig. 6B) and TNF concentration.5 ng/ml (Fig. 6C).
Recombinant IFNc and TNF induce epithelial CXCL10
mRNA expression, but at a level much lower than that
induced by activated T cells
As neutralizing IFNc and TNF largely abrogated T cells-
induced epithelial CXCL10 expression, we examined if basolateral
treatment of HNEC with a mixture of recombinant IFNc plus
TNF (50 ng/ml each) stimulated epithelial CXCL10 expression. A
48 h exposure of HNEC to IFNc plus TNF resulted in 11+1.5 fold
increase in CXCL10 mRNA level, much less than that observed in
HNEC cultured in the presence of activated T cells.
Activated T cells inhibit virus replication in HNEC partially
through the nitric oxide pathway
NO inhibits viral replication [14]. Since activated T cells
significantly induced NOS2 in HNEC, we asked whether this
would impact HRV14 replication in infected HNEC. In the
presence of activated T cells, the level of viral RNA in infected
HNEC was reduced by 80.460.03% compared to that observed in
infected cells cultured without T cells (p,0.05). To assess the role
of NO in viral replication, we used FP and L-NIL that inhibits
NOS2 mRNA expression and activity, respectively. Addition of FP
and L-NIL in co-cultures resulted in 55612% reduction in
epithelial NOS2 mRNA, and 8466% reduction in basolateral
secretion of nitrite induced by T cells, respectively (Fig. 7A). Under
these conditions, T cells were less effective in reducing viral
replication since higher amounts of viral RNA were observed in
infected HNEC, although the difference was not statistically
significant (Fig. 7B).
Discussion
In this study, we show that T lymphocytes promote the antiviral
and inflammatory response of differentiated human airway
epithelial cells to HRV, highlighting important cross-talks between
epithelial and T cells.
After a short period (6 h) exposure to 5000 TCID50 of HRV14,
the virus particles that enter differentiated HNEC are fully capable
of replication. This might be due to the lack of type 1 IFNs and
NO responses, two systems known to block the spread of virus
infection. Indeed, we did not observe induction of IFNb and
NOS2 mRNA expression in HNEC, and did not detect IFNb
protein and NO in the extracellular media 40 h after HRV14
infection in the absence of activated T cells. Our inability to detect
up-regulation of the genes important in antiviral defense cannot be
ascribed to insufficient infection of HNEC since the viral dose used
in our study did allow productive infection of HNEC. Of note, this
viral dose is 5 times higher than that usually employed in
experimental inoculation studies, reported to be effective in
inducing significant cold symptoms[20,24,25]. Hence our obser-
vation in nasal epithelial cells differ from those previously reported
for bronchial epithelial cells [27]. This may be related to the
degree of infection, the cell’s origin (upper or lower airways) and/
or differentiation status. Of note, highly polarized cells like those
used in our study were reported to be much less susceptible to virus
infection [28]. In addition, no significant induction of the
neutrophil attractant CXCL8 and the pro-inflammatory cytokine
IL-6 was observed in our cells following HRV14 challenge, which
is in accordance with data obtained with fully differentiated
epithelial cells grown with an air-liquid interface [28], but in
contrast with those obtained with undifferentiated tracheal/
bronchial primary epithelial cells or cell lines grown as submerged
monolayers [11–13]. We did observe a consistent and significant
induction of mRNA and secreted protein of CXCL10, a potent
chemo-attractant for T cells. This observation supports the current
opinion that epithelial cells are the primary source of CXCL10
during HRV infection. It has been reported that CXCL10
production increased in airway epithelium after in vivo and in
vitro HRV infection [6,29–31], in airway secretions during
symptomatic in vivo HRV infections, and in serum of asthmatic
patients during virus-induced exacerbations [32]. Taken altogeth-
er, our results show that apart from CXCL10, HRV infection by
itself did not induce significant antiviral and inflammatory
responses in fully differentiated airway epithelial cells with intact
tight junctions.
Interestingly, activated T cells alone promote a marked increase
in CXCL10, IL-8, IL-6 and NOS2 expression in HNEC. The
effect was particularly strong for CXCL10, thousands times
greater than that induced by HRV14. Epithelial CXCL10
induction is mediated by T cells derived soluble factors because
activated T cells were not in direct contact with HNEC in our co-
cultures. Our data obtained with neutralizing antibodies, T cell
clones secreting different IFNc and TNF amounts, and increasing
numbers of T cells, clearly indicate that IFNc and TNF were the
main inducers of epithelial CXCL10. Our observation that
Figure 6. Epithelial CXCL10 protein secreted into the basolateral compartment increases with increasing T cells numbers and
increasing IFNc and TNF amounts, reaching a plateau at high concentrations.A constant number of HNEC (0.5610
6 cells) was co-cultured
with increasing numbers of activated T cells (0.1, 0.5, 2.5, 5610
6 cells). CXCL10 protein amounts secreted by HNEC into the basolateral media are
expressed as a function of the numbers of T cells in co-cultures (A) and the amounts of IFNc (B) and TNF (C) secreted by increasing numbers of T cells.
doi:10.1371/journal.pone.0026293.g006
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and TNF concentrations points to saturation of IFNc/TNF
receptors. However, recombinant IFNc and TNF added as a
single bolus at concentrations (50 ng/ml) equivalent or greater
than those secreted by high numbers of T cells induced only a
modest increase in epithelial CXCL10 mRNA expression. This
might be due to the fact that exogenously added cytokines are
short-lived in the culture media while in co-cultures, cytokines are
continuously produced by activated T cells. Of note, exogenous
TNF added alone had no effect (data not shown) implicating that
in co-cultures the stimulating effect of TNF on epithelial
CXCL10 might be mediated through INFc induced by TNF.
Taken altogether these data highlight the importance of
continuous interactions between immune and epithelial cells
resulting in uninterrupted production of cytokines to maintain
transduction signals for host responses. The observed additive
effects of IFNc and TNF on CXCL10 suggest that more than one
signaling pathway was involved, similar to signaling in human
monocytes [33] and airway smooth muscle cells [34]. By contrast,
the effects of IFNc and TNF on NOS2 are not additive,
suggesting that they might act on similar transduction pathways.
Furthermore, IFNc and TNF were only partially effective in
inducing epithelial NOS2, indicating that other soluble factors
were required.
A recent report has revealed active interactions between human
bronchial epithelial cells, monocytes and HRV16 resulting in a
synergistic induction of CXCL10 and CCL3 in bronchial
epithelial cells. In the latter work, epithelial cells were submerged
undifferentiated cultures, and in direct contact with HRV16 and
monocytes [31]. As such, this experimental system is most likely
representative of severe in vivo infection conditions with immune
cells infiltrating the mucosa. Our experimental model of polarized
airway epithelial cells cultured on semi-permeable membrane and
separated from activated T cells is more appropriate to study early
interactions through soluble factors when the epithelium is still
intact after a mild HRV infection.
Interestingly, activated T cells markedly reduced virus
replication in HNEC, may be through IFNs and/or NO known
to activate different genes leading to apoptosis of infected cells,
thereby limiting viral replication and release [3,35]. A role for
type 1 IFNs can be ruled out as we detected no increase in IFNb
gene expression in infected HNEC co-incubated with T cells
(data not shown). In contrast, NO is involved in viral clearance,
since in most cases when NO production is inhibited HRV14
RNA levels are higher in infected HNEC. This is in keeping with
clinical observations reporting that patients with high levels of
exhaled NO clear virus more rapidly and have lower symptom
scores [14].
In conclusion, except for CXCL10, highly differentiated
human airway epithelial cells are quite unresponsive to low level
of HRV infection in terms of antiviral and inflammatory
responses, which become largely significant in the presence of
activated T cells. It is expectable that a mild viral infection of
the mucosal epithelium in vivo promotes further airway
inflammation by triggering epithelial CXCL10 production,
allowing accumulation of activated T lymphocytes which in
turn enhance epithelial chemokines and cytokines production.
On the other hand, activated T cells recruited to the site of
infection help epithelial cells to clear viruses through production
of IFNc and TNF, and induction of epithelial NOS2 expression.
Consequently, epithelial cells are important effector cells in
immune response and activated T lymphocytes are a major
player in HRV-induced airway inflammation by linking innate
and adaptive immunity.
Figure 7. Activated T cells inhibit virus replication in infected HNEC partially through the NO pathway. HNEC were exposed apically to
HRV14, washed thoroughly then co-cultured with activated T cells in the presence or absence of FP and L-NIL, inhibitors of NOS2 mRNA and activity,
respectively. (A) NO secretion in the basolateral compartment and (B) viral RNA levels. NO is expressed as nitrite, the stable oxidation product of NO
(mM). Viral RNAs was measured by real-time PCR and expressed as fold change relative to those observed in infected HNEC cultured in the absence of
activated T cells. *p,0.05
doi:10.1371/journal.pone.0026293.g007
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